We are live on ! Find out more
OIC

Orion Investment Company Portfolio holdings

AUM $343M
1-Year Est. Return 52.59%
This Fund
S&P 500
This Quarter Est. Return
+18.15%
1 Year Est. Return
+52.59%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$315M
AUM Growth
+$32.2M
Cap. Flow
-$7.49M
Cap. Flow %
-2.38%
Top 10 Hldgs %
59.36%
Holding
72
New
2
Increased
26
Reduced
15
Closed
2
Avg Time Held
4.4 quarters
Top 10 Avg Time Held
3.4 quarters
Top 20 Avg Time Held
3.9 quarters

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$1.19M
2
ASML icon
ASML
ASML
+$1.09M
3
BIIB icon
Biogen
BIIB
+$882K
4
RGTI icon
Rigetti Computing
RGTI
+$838K
5
OKLO
Oklo
OKLO
+$660K

Sector Composition

Rank Sector Weight
1 Technology 48.08%
2 Healthcare 17.78%
3 Industrials 12.08%
4 Consumer Staples 5.91%
5 Energy 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.88T
$54.7M 17.37%
105,512
+94
+0.1% +$48K
2024 Q2
5 quarters
PLTR icon
2
Palantir
PLTR
$478B
$24.5M 7.79%
134,364
-161
-0.1% -$26.1K
2024 Q2
5 quarters
QCOM icon
3
Qualcomm
QCOM
$188B
$20.1M 6.39%
120,914
-376
-0.3% -$59.6K
2024 Q2
5 quarters
REGN icon
4
Regeneron Pharmaceuticals
REGN
$76.1B
$17.2M 5.47%
30,637
+366
+1% +$207K
2024 Q2
5 quarters
IONQ icon
5
IonQ
IONQ
$16B
$16.9M 5.38%
275,234
+3,770
+1% +$177K
2024 Q2
5 quarters
IONS icon
6
Ionis Pharmaceuticals
IONS
$7.2B
$14.7M 4.67%
224,705
+7,335
+3% +$358K
2024 Q2
5 quarters
PH icon
7
Parker-Hannifin
PH
$119B
$10.4M 3.32%
13,765
+50
+0.4% +$36.9K
2024 Q2
5 quarters
CMI icon
8
Cummins
CMI
$71.6B
$9.59M 3.05%
22,711
+83
+0.4% +$31.8K
2024 Q2
5 quarters
XOM icon
9
ExxonMobil
XOM
$693B
$9.56M 3.04%
84,768
+573
+0.7% +$63.7K
2024 Q2
5 quarters
PG icon
10
Procter & Gamble
PG
$350B
$9.08M 2.89%
59,102
+293
+0.5% +$45.8K
2024 Q2
5 quarters
ABT icon
11
Abbott
ABT
$170B
$8.53M 2.71%
63,659
-599
-0.9% -$78.6K
2024 Q2
5 quarters
NEE icon
12
NextEra Energy
NEE
$161B
$7.71M 2.45%
102,140
+393
+0.4% +$28.7K
2024 Q2
5 quarters
SHOP icon
13
Shopify
SHOP
$212B
$7.24M 2.3%
48,722
+4,223
+9% +$573K
2024 Q2
5 quarters
HSY icon
14
Hershey
HSY
$32.7B
$7.17M 2.28%
38,356
+716
+2% +$130K
2024 Q2
5 quarters
GD icon
15
General Dynamics
GD
$89.3B
$6.79M 2.16%
19,907
+106
+0.5% +$33.4K
2024 Q2
5 quarters
RGLD icon
16
Royal Gold
RGLD
$19.6B
$5.56M 1.77%
27,730
+621
+2% +$107K
2024 Q2
5 quarters
BIIB icon
17
Biogen
BIIB
$32.3B
$5.52M 1.76%
39,429
+6,528
+20% +$882K
2024 Q2
5 quarters
ASML icon
18
ASML
ASML
$680B
$5.16M 1.64%
5,325
+1,381
+35% +$1.09M
2024 Q2
5 quarters
INTC icon
19
Intel
INTC
$566B
$5.02M 1.59%
149,536
-900
-0.6% -$21.8K
2024 Q2
5 quarters
CCJ icon
20
Cameco
CCJ
$37.9B
$4.24M 1.35%
50,580
+5,300
+12% +$411K
2024 Q2
5 quarters
RGTI icon
21
Rigetti Computing
RGTI
$4.72B
$4.15M 1.32%
139,230
+47,795
+52% +$838K
2025 Q1
2 quarters
IOVA icon
22
Iovance Biotherapeutics
IOVA
$6.03B
$4.02M 1.28%
1,851,784
-486,779
-21% -$1.15M
2024 Q2
5 quarters
CDNS icon
23
Cadence Design Systems
CDNS
$96.1B
$3.66M 1.16%
10,426
+193
+2% +$66.4K
2024 Q2
5 quarters
AAPL icon
24
Apple
AAPL
$4.97T
$3.64M 1.16%
14,313
– –
2024 Q2
5 quarters
HII icon
25
Huntington Ingalls Industries
HII
$10.4B
$3.61M 1.15%
12,556
+145
+1% +$38.6K
2024 Q2
5 quarters

Similar funds

Orion Investment Company's Q3 2025 Portfolio in Review

As of Q3 2025, Orion Investment Company held 72 positions worth $315M, up 11% from $282M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Orion Investment Company's Q3 2025 filing shows 2 new, 26 increased, 15 reduced and 2 closed positions. Its largest new stake was Broadcom: 3,886 shares worth $1.28M. The largest sale was Blueprint Medicines, an estimated $13.6M.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 44% a quarter earlier, followed by Healthcare and Industrials.

  • Orion Investment Company's largest Q3 2025 buy was Broadcom: 3,886 shares worth $1.28M.
  • Orion Investment Company added most to ASML in Q3 2025, an estimated $1.09M increase.
  • Orion Investment Company's biggest Q3 2025 reduction was Iovance Biotherapeutics, cutting an estimated $1.15M.
  • Orion Investment Company fully exited Blueprint Medicines in Q3 2025, selling an estimated $13.6M.
  • Orion Investment Company's ten largest holdings make up 59% of its $315M portfolio in Q3 2025.
  • Orion Investment Company opened 2 new positions and closed 2 in Q3 2025.
  • Orion Investment Company's portfolio value rose 11% quarter-over-quarter to $315M.

Based on Orion Investment Company's 13F filing for Q3 2025, filed 13 Nov 2025.